Does GLS by feature-tracking CMR predict medium-term MACE better than LVEF and CMR markers of infarct severity in revascularized STEMI patients?
GLS by feature-tracking CMR provides superior and incremental prognostic value over LVEF and traditional CMR markers for predicting MACE in revascularized STEMI patients.
GLS by feature-tracking-CMR strongly and independently predicted the occurrence of medium-term MACE in contemporary revascularized ST-elevation myocardial infarction patients. Importantly, the prognostic value of GLS was superior and incremental to LVEF and CMR markers of infarct severity.
Reindl et al. (Fri,) studied this question.